Literature DB >> 1270149

Antibody-dependent cell-mediated cytotoxicity in cows: comparison of effector cell activity against heterologous erthrocyte and herpesvirus-infected bovine target cells.

B T Rouse, R C Wardley, L A Babiuk.   

Abstract

Bovine peripheral blood leukocytes (PBL) and cells collected from the bovine mammary gland were assayed for antibody-dependent cell-mediated cytotoxicity (ADCC) against chicken erythrocyte (CRBC) and bovine herpesvirus-infected bovine kidney cell targets. Bovine antisera were used to sensitize target cells. Both PBL and mammary leukocytes expressed ADCC, with the latter cell population having greater activity against both target cells. Only the CRBC target cells were killed by nonadherent PBL and phagocyte-depleted PBL. Nonadherent mammary leukocytes, rich in monocytes and macrophages, did kill virus-infected target cells. Carbonyl iron-treated mammary leukocytes failed to kill virus-infected targets but could destroy CRBC targets. Antimacrophage serum inhibited lysis of both CRBC and virus-infected targets, but antilymphocyte serum only inhibited CRBC killing. These observations indicated that at least two kinds of cells could mediate ADCC against CRBC but only cells of the mononuclear phagocytic series could kill virus-infected target cells. The herpesvirus-infected target cells became susceptible to ADCC 9 h after virus infection. A case is made for investigating the phenomenon of ADCC using in vitro systems that closely mimic the in vivo situation. The possible role of the ADCC mechanism as instrumental in causing recovery from herpesvirus infections is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270149      PMCID: PMC420777          DOI: 10.1128/iai.13.5.1433-1441.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes.

Authors:  B T Rouse; L A Babiuk
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

3.  Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell.

Authors:  A H Greenberg; L Shen; L Walker; A Arnaiz-Villena; I M Roitt
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

4.  Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell.

Authors:  A H Greenberg; L Hudson; L Shen; I M Roitt
Journal:  Nat New Biol       Date:  1973-03-28

5.  The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Gen Virol       Date:  1973-06       Impact factor: 3.891

6.  Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells.

Authors:  J C Scornik
Journal:  J Immunol       Date:  1974-11       Impact factor: 5.422

7.  Lysis of antibody-treated human erythrocytes by human leukocytes and macrophages in tissue culture.

Authors:  G Holm
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

8.  Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes.

Authors:  R G Miller; M Dunkley
Journal:  Cell Immunol       Date:  1974-11       Impact factor: 4.868

9.  Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.

Authors:  G Trinchieri; P Bauman; M De Marchi; Z Tökés
Journal:  J Immunol       Date:  1975-07       Impact factor: 5.422

10.  A comparison of the effector cells involved in cell-mediated lympholysis and antibody-dependent cell-mediated cytotoxicity in man.

Authors:  H R MacDonald; G D Bonnard
Journal:  Scand J Immunol       Date:  1975       Impact factor: 3.487

View more
  28 in total

1.  Immune interferon production by lymphoid cells: role in the inhibition of herpesviruses.

Authors:  L A Babiuk; B T Rouse
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

Review 2.  Coxsackievirus infection as a trigger of cardiac autoimmunity.

Authors:  L J Wolfgram; N R Rose
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Mechanisms of resistant of herpesviruses: comparison of the effectiveness of different cell types in mediating antibody-dependent cell-mediated cytotoxicity.

Authors:  A S Grewal; B T Rouse; L A Babiuk
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

4.  Enhancement of antibody-dependent cell-mediated cytotoxicity of herpesvirus-infected cells by complement.

Authors:  B T Rouse; A S Grewal; L A Babiuk; Y Fujimiya
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

Review 5.  Mechanisms of recovery from Herpesvirus infections -a review.

Authors:  B T Rouse; L A Babiuk
Journal:  Can J Comp Med       Date:  1978-10

6.  The establishment of continuous macrophage cell lines from peripheal blood monocytes.

Authors:  R C Wardley; M J Lawman; F Hamilton
Journal:  Immunology       Date:  1980-01       Impact factor: 7.397

7.  Destruction of virus infected cells by neutrophils and complement.

Authors:  A S Grewal; B T Rouse
Journal:  Experientia       Date:  1980-03-15

8.  Murine cellular cytotoxicity to syngeneic and xenogeneic herpes simplex virus-infected cells.

Authors:  S Kohl; D B Drath; L S Loo
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Inhibition of glycosylation of bovine herpesvirus 1 glycoproteins by the thymidine analog (E)-5-(2 Bromovinyl)-2'-deoxyuridine.

Authors:  V Misra; R C Nelson; L A Babiuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Cell-mediated cytotoxic responses in lungs following a primary bovine herpes virus type 1 infection.

Authors:  M Campos; P Griebel; H Bielefeldt Ohmann; L A Babiuk
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.